Stock market announcement archive

Lifecare ASA: Public retail offering successfully placed

October 15, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company“) on 8 October […]
Read more

Lifecare ASA: Last day of application period

October 15, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company“) on 8 October […]
Read more

Lifecare presentation at the Diabetes Technology Meeting 2024.

October 14, 2024
Bergen, Norway, October 14, 2024: Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM) will present a poster at the Diabetes Technology Meeting (DTM) in Burlingame, California, an international diabetes technology conference hosted by the Diabetes Technology Society. As the DTM returns as a face-to-face meeting after […]
Read more

Lifecare ASA: Application deadline for applicants using Nordnet webservice

October 14, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company“) on 8 October […]
Read more

Lifecare ASA: Mandatory notification of trade

October 10, 2024
Reference is made to the stock exchange announcement published by Lifecare ASA (the “Company”) on 8 October 2024, regarding the commencement of the application period in the public retail offering (the “Offering”) of up to 1,000,000 new shares (the “Offer Shares”). Hannibal Invest AS, a company closely associated with Hans Hekland, board member of the […]
Read more

LIFE – Study protocol has been finalized for submission to regulatory authorities

October 10, 2024
Bergen, Norway, 10 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can announce that we have internally concluded on the next human study protocol to progress with our clinical sensor development towards regulatory approval. Reference is made to the Q2 report 27 August […]
Read more

LIFE – Longevity trial: Biopsy and bacteriological examination confirm no unexpected foreign body reactions after removal of implant

October 8, 2024
Bergen, Norway, 08 October 2024: Today, Lifecare ASA (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), can confirm no unexpected tissue or body response based on bacteriological and biopsy tests after removal of the implanted sensor used in first longevity study. In addition, post study testing of the […]
Read more

Lifecare ASA: Launch of public retail offering and commencement of application period

October 8, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company“) on 2 October […]
Read more

Lifecare ASA: Approval and publication of prospectus

October 4, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made by Lifecare ASA (the “Company“) on 2 October […]
Read more

Lifecare ASA: Announcement of terms of public retail offering

October 2, 2024
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. Reference is made to the stock exchange announcement made on 27 September 2024, where it was announced […]
Read more